Overcoming barriers to introduce and scale the HPV vaccine in Middle Income Countries: Key takeaways from Linked’s workshop held on July 11-12th, 2023

LOOK AT THIS IF YOU'RE INTERESTED IN:

Learning about country experiences in introducing and scaling up the HPV vaccine.

HOW YOU CAN USE THIS MATERIAL:

Immunisation practitioners can learn from the experiences of Linked countries regarding overcoming barriers and challenges with introduction and scale-up of the HPV vaccine and adapt the lessons to their own context.

OVERVIEW:

The Linked Immunisation Action Network welcomed immunisation practitioners from four Middle Income Countries along with global and regional technical experts, for a workshop focused on New Vaccines Introduction in Middle Income Countries: Overcoming barriers to introduce and scale the HPV vaccine. Held in Istanbul, Turkey, on July 11th and 12th 2023, the objective of this workshop was to facilitate the sharing of approaches, good practices, and lessons learned to support a successful introduction of the HPV vaccine in each participating country. Country government teams from Tunisia, the Philippines, Mongolia, and Vietnam participated, along with experts from academic and partner organizations, including WHO, UNICEF, CDC, and Jhpiego. This brief outlines key learnings and takeaways that arose from the workshop.

You May Also Like

Linked Country Case Study: Strengthening Tunisia’s HPV Vaccine Introduction

The Linked Immunisation Action Network played a pivotal role in supporting Tunisia’s HPV vaccine introduction by leveraging peer-to-peer learning and cross-regional collaboration. Tunisia joined the network in 2023 during critical preparations for its school-based HPV rollout targeting 12-year-old girls. Participation in global workshops, including an Istanbul session with peers like the Philippines and Mongolia, provided … Read More

Download
File size: 2.56M

Health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in LMICs: An analysis of Indonesia

A study in PLOS ONE evaluates the feasibility and impact of a single-dose 9-valent HPV vaccination program in Indonesia, focusing on its potential to reduce cervical cancer rates. The research highlights that a single-dose regimen is cost-effective, logistically simpler, and more accessible, particularly in low-resource settings. It also emphasizes the importance of community engagement and … Read More

HPV introduction and implementation: Case studies from Africa and South Asia

This special issue of Vaccine focuses on innovations and challenges in strengthening immunization programs globally. Key themes include the integration of new vaccine technologies, such as mRNA vaccines, into existing systems, and strategies to address inequities in vaccine access. Several articles highlight the importance of data-driven decision-making, supply chain resilience, and workforce training to improve … Read More